Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$6.3M
Filings
169
Firms Hired
9
Active Period
2001–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Strengthening Public Health Emergency Response Act of 2016
2016 · third_quarter · Firm: PODESTA GROUP, INC.
Biodefense product development and acquisition issues S. 2055/H.R. 3299 - Medical Countermeasures Innovation Act
Client expense: — · Firm income: $40,000
Matched citations: H.R. 3299
Medical Countermeasure Innovation Act of 2016
2016 · third_quarter · Firm: PODESTA GROUP, INC.
Biodefense product development and acquisition issues S. 2055/H.R. 3299 - Medical Countermeasures Innovation Act
Client expense: — · Firm income: $40,000
Matched citations: S. 2055
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2012 · fourth_quarter · Firm: PHARMATHENE, INC.
Advocacy for Pandemic and All-Hazards Preparedness Reauthorization Act 2012 (PAHPRA) in U.S. House (HR 2405) and U.S. Senate (S.1855). Encourage continued funding for the Biodefense Advanced Research and Development Authority (BARDA) at HHS with the House Labor-HHS Appropriations Subcommittee and Senate HELP and Labor-HHS Appropriations Committee. Continued education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.
Client expense: $73,273 · Firm income: —
Matched citations: HR 2405
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2012 · third_quarter · Firm: PHARMATHENE, INC.
Advocacy for Reauthorization of Pandemic All-Hazards Preparedness Act (PAHPA) in House (HR 2405) and Senate (S.1855). Advocacy for House and Senate Labor-HHS Appropriations funding allocation in FY-2013 and FY-2014 for the Biodefense Advanced Research and Development Authority (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.
Client expense: $79,149 · Firm income: —
Matched citations: HR 2405
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2012 · second_quarter · Firm: PHARMATHENE, INC.
Advocacy for Reauthorization of Pandemic and All Hazards Preparedness Act (PAHPA) in both House (HR 2405) and Senaete (S.1855). Advocay for funding in House and Senate Labor-HHS Appropriations bills for the Biodefense Advanced Research and Development Agency (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA)anthrax vaccine.
Client expense: $103,263 · Firm income: —
Matched citations: HR 2405
Coltsville National Historical Park Act
2012 · first_quarter · Firm: PHARMATHENE, INC.
Advocacy in House and Senate for Bills to Reauthorize the Pandemic and All-Hazards Preparedness Act (H.R. 2504 and S. 1855). Advocacy in Congress for HHS/BARDA funding in FY-2013 budget (Senate Labor-HHS Appropriations and House Labor-H Appropriations. Education for Members of Congress and Staff on biodefense medical countermeasures, especially anthrax recombinant vaccine.
Client expense: $103,945 · Firm income: —
Matched citations: H.R. 2504
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2011 · third_quarter · Firm: PHARMATHENE, INC.
House and Senate Reauthorization of Pandemic and All-Hazards Preparedness Act (PAHPA; H.R. 2405; S. 1855), FY-2012 Appropriations Continuing resolution (H.R. 2608), FY-2012 Labor-HHS Appropriations, Increased funding for BARDA at HHS, Medical Countermeasures (MCM's) for bioterrorism threats, specifically 2nd generation Anthrax rPA Vaccine and Anthrax Antitoxin.
Client expense: $224,325 · Firm income: —
Matched citations: H.R. 2405
Continuing Appropriations Act, 2012
2011 · third_quarter · Firm: PHARMATHENE, INC.
House and Senate Reauthorization of Pandemic and All-Hazards Preparedness Act (PAHPA; H.R. 2405; S. 1855), FY-2012 Appropriations Continuing resolution (H.R. 2608), FY-2012 Labor-HHS Appropriations, Increased funding for BARDA at HHS, Medical Countermeasures (MCM's) for bioterrorism threats, specifically 2nd generation Anthrax rPA Vaccine and Anthrax Antitoxin.
Client expense: $224,325 · Firm income: —
Matched citations: H.R. 2608
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
2011 · fourth_quarter · Firm: PHARMATHENE, INC.
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) in the House (H.R. 2405) and the Seante (S. 1855). Education and awareness of the need for medical countermeasures (MCM's) for chemcial and biological threats. Need for second generation recombinant anthrax vaccine (rPA).
Client expense: $211,875 · Firm income: —
Matched citations: H.R. 2405
Prioritize Spending Act of 2011
2011 · third_quarter · Firm: PHARMATHENE, INC.
House and Senate Reauthorization of Pandemic and All Hazards preparedness Act (PAHPA; H.R. 2402), FY-2012 Appropriations Continuing Resolution (H.R. 2608), FY-2012 Labor-HHS Approporiations, Increased funding for BARDA at HHS, Medical Countermeasures (MCMs) for biodefense thrwats, specifically 2nd Generation anthrax rPA Vaccine and anthrax antitoxin
Client expense: $299,325 · Firm income: —
Matched citations: H.R. 2402
Continuing Appropriations Act, 2012
2011 · third_quarter · Firm: PHARMATHENE, INC.
House and Senate Reauthorization of Pandemic and All Hazards preparedness Act (PAHPA; H.R. 2402), FY-2012 Appropriations Continuing Resolution (H.R. 2608), FY-2012 Labor-HHS Approporiations, Increased funding for BARDA at HHS, Medical Countermeasures (MCMs) for biodefense thrwats, specifically 2nd Generation anthrax rPA Vaccine and anthrax antitoxin
Client expense: $299,325 · Firm income: —
Matched citations: H.R. 2608
Montgomery GI Bill Degree Extension Act of 2007
2010 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.3686, Labor, Health and Human Services, and Education Appropriations Act 2011; Issues related to Biodefense Advanced Research and Development Authority (BARDA); Biodefense awareness of threat and funding for medical countermeasures; S.3607, Department of Homeland Security Appropriations Act, 2011; Issues related to biodefense education and funding; Anthrax vaccine issues; Chemical nerve agent bioscavenger FY2011 Defense Appropriations (S.3800) funding; FY 2011 Consolidated Appropriations Act, a substitute amendment to the House passed Continuing Resolution (H.R. 3082).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3082
Department of Homeland Security Appropriations Act, 2011
2010 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.3686, Labor, Health and Human Services, and Education Appropriations Act 2011; Issues related to Biodefense Advanced Research and Development Authority (BARDA); Biodefense awareness of threat and funding for medical countermeasures; S.3607, Department of Homeland Security Appropriations Act, 2011; Issues related to biodefense education and funding; Anthrax vaccine issues; Chemical nerve agent bioscavenger FY2011 Defense Appropriations (S.3800) funding; FY 2011 Consolidated Appropriations Act, a substitute amendment to the House passed Continuing Resolution (H.R. 3082).
Client expense: — · Firm income: $30,000
Matched citations: S.3607
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
2010 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.3686, Labor, Health and Human Services, and Education Appropriations Act 2011; Issues related to Biodefense Advanced Research and Development Authority (BARDA); Biodefense awareness of threat and funding for medical countermeasures; S.3607, Department of Homeland Security Appropriations Act, 2011; Issues related to biodefense education and funding; Anthrax vaccine issues; Chemical nerve agent bioscavenger FY2011 Defense Appropriations (S.3800) funding; FY 2011 Consolidated Appropriations Act, a substitute amendment to the House passed Continuing Resolution (H.R. 3082).
Client expense: — · Firm income: $30,000
Matched citations: S.3686
Department of Defense Appropriations Act, 2011
2010 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.3686, Labor, Health and Human Services, and Education Appropriations Act 2011; Issues related to Biodefense Advanced Research and Development Authority (BARDA); Biodefense awareness of threat and funding for medical countermeasures; S.3607, Department of Homeland Security Appropriations Act, 2011; Issues related to biodefense education and funding; Anthrax vaccine issues; Chemical nerve agent bioscavenger FY2011 Defense Appropriations (S.3800) funding; FY 2011 Consolidated Appropriations Act, a substitute amendment to the House passed Continuing Resolution (H.R. 3082).
Client expense: — · Firm income: $30,000
Matched citations: S.3800
Early Treatment for HIV Act of 2007
2010 · third_quarter · Firm: DENTONS US LLP
Issues related to Bioterrorism and Homeland Security. HR 3326 - Department of Defense Appropriations Act 2010; BARDA funding and emergency prepardness programs.
Client expense: — · Firm income: $10,000
Matched citations: HR 3326
Department of Homeland Security Appropriations Act, 2011
2010 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.3686, Labor Health and Human Services Appropriations, issues related to Biodefense Advanced Research and Development Authority (BARDA), biodefense awareness of threat and funding for medical countermeasures; S.3607, Homeland Security Appropriations, issues related to biodefense education and funding; Anthrax vaccine issues; chemical nerve agent bioscavenger FY2011 Defense Appropriations (S.3800) funding.
Client expense: — · Firm income: $30,000
Matched citations: S.3607
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
2010 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.3686, Labor Health and Human Services Appropriations, issues related to Biodefense Advanced Research and Development Authority (BARDA), biodefense awareness of threat and funding for medical countermeasures; S.3607, Homeland Security Appropriations, issues related to biodefense education and funding; Anthrax vaccine issues; chemical nerve agent bioscavenger FY2011 Defense Appropriations (S.3800) funding.
Client expense: — · Firm income: $30,000
Matched citations: S.3686
Department of Defense Appropriations Act, 2011
2010 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
S.3686, Labor Health and Human Services Appropriations, issues related to Biodefense Advanced Research and Development Authority (BARDA), biodefense awareness of threat and funding for medical countermeasures; S.3607, Homeland Security Appropriations, issues related to biodefense education and funding; Anthrax vaccine issues; chemical nerve agent bioscavenger FY2011 Defense Appropriations (S.3800) funding.
Client expense: — · Firm income: $30,000
Matched citations: S.3800
Early Treatment for HIV Act of 2007
2010 · second_quarter · Firm: DENTONS US LLP
Issues related to Bioterrorism and Homeland Security. HR 3326 - Department of Defense Appropriations Act 2010; BARDA funding and emergency prepardness programs.
Client expense: — · Firm income: $20,000
Matched citations: HR 3326
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
2010 · first_quarter · Firm: FOLEY HOAG LLP
Health Care and Education Affordability Reconciliation Act (H.R. 4872); Implementation of biodefense preparedness relate legislation and Department of Health and Human Services Appropriations
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4872
Early Treatment for HIV Act of 2007
2010 · first_quarter · Firm: DENTONS US LLP
Issues related to Bioterrorism and Homeland Security. HR 3326 - Department of Defense Appropriations Act 2010; BARDA funding and emergency prepardness programs.
Client expense: — · Firm income: —
Matched citations: HR 3326
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: FOLEY HOAG LLP
Implementation of biodefense preparedness related legislation and Department of Health and Human Services Appropriations Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Client expense: — · Firm income: $30,000
Matched citations: H.R.3590
Implementation of biodefense preparedness related legislation and Department of Health and Human Services Appropriations Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Client expense: — · Firm income: $30,000
Matched citations: HR 3962
WMD Prevention and Preparedness Act of 2009
2009 · fourth_quarter · Firm: PHARMATHENE, INC.
HR-3293 Department of Labor, Health and Human Services and Education Appropriations Act for 2010: All provisions relating to development, acquisition and stockpilingof biodefense vaccines and therapeutics; Appropriations advocacy; BARDA funding. HHS procurement contract of recombinant anthrax vaccines. S.1649 - WMD Prevention and Preparedness Act of 2009 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines and therapeutics. Support and Funding for the Biomedical Advanced Research and Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines and therapeutics. Department of Defense Chemical- Biological Medical Systems (CBMS) funding for organophosphate bioscavenger advanced research and development.
Client expense: $208,877 · Firm income: —
Matched citations: S.1649
Source: Senate LDA